Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A

NCT01610414 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1877

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: Herpes Zoster vaccine GSK1437173A
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline